Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Romano

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Nucleic Acids Research|October 24, 2008
UCbase & miRfunc: a database of ultraconserved sequences and microRNA functionCristian Taccioli, Enrica Fabbri, Rosa Visone, et al.
Oncotarget|November 12, 2015
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3bGiuseppina Roscigno, Cristina Quintavalle, Elvira Donnarumma, et al.
Frontiers in Oncology|October 23, 2023
A plasma miRNA-based classifier for small cell lung cancer diagnosisMichela Saviana, Giulia Romano, Joseph McElroy, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2016
miR-579-3p controls melanoma progression and resistance to target therapyLuigi Fattore, Rita Mancini, Mario Acunzo, et al.
Cancer Cell|December 8, 2009
RETRACTED: miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulationMichela Garofalo, Gianpiero Di Leva, Giulia Romano, et al.
Cancer Cell|October 28, 2022
Retraction Notice to: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 DownregulationMichela Garofalo, Gianpiero Di Leva, Giulia Romano, et al.
Genes|November 24, 2022
Extracellular Vesicle MicroRNA in Malignant Pleural EffusionSamira Shojaee, Giulia Romano, Trinidad M Sanchez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2017
RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21Tae Jin Lee, Ji Young Yoo, Dan Shu, et al.
Nature Medicine|December 14, 2011
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancersMichela Garofalo, Giulia Romano, Gianpiero Di Leva, et al.
Nature Medicine|October 4, 2022
Retraction Note: EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancersMichela Garofalo, Giulia Romano, Gianpiero Di Leva, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Nucleic Acids Research|October 24, 2008
UCbase & miRfunc: a database of ultraconserved sequences and microRNA functionCristian Taccioli, Enrica Fabbri, Rosa Visone, et al.
Oncotarget|November 12, 2015
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3bGiuseppina Roscigno, Cristina Quintavalle, Elvira Donnarumma, et al.
Frontiers in Oncology|October 23, 2023
A plasma miRNA-based classifier for small cell lung cancer diagnosisMichela Saviana, Giulia Romano, Joseph McElroy, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2016
miR-579-3p controls melanoma progression and resistance to target therapyLuigi Fattore, Rita Mancini, Mario Acunzo, et al.
Cancer Cell|December 8, 2009
RETRACTED: miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulationMichela Garofalo, Gianpiero Di Leva, Giulia Romano, et al.
Cancer Cell|October 28, 2022
Retraction Notice to: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 DownregulationMichela Garofalo, Gianpiero Di Leva, Giulia Romano, et al.
Genes|November 24, 2022
Extracellular Vesicle MicroRNA in Malignant Pleural EffusionSamira Shojaee, Giulia Romano, Trinidad M Sanchez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2017
RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21Tae Jin Lee, Ji Young Yoo, Dan Shu, et al.
Nature Medicine|December 14, 2011
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancersMichela Garofalo, Giulia Romano, Gianpiero Di Leva, et al.
Nature Medicine|October 4, 2022
Retraction Note: EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancersMichela Garofalo, Giulia Romano, Gianpiero Di Leva, et al.
Pageof 10